Demonstration of changes in plasma cell subsets in multiple myeloma

被引:19
作者
Ayliffe, Michael John [1 ]
Davies, Faith Elizabeth [2 ]
de Castro, David [2 ]
Morgan, Gareth John [2 ]
机构
[1] St Helier Hosp, Dept Immunol, Wrythe Lane, Carshalton SM3 8NR, Surrey, England
[2] Royal Marsden NHS Fdn Trust, Sect Haematooncol, London, England
关键词
multiple myeloma; bone marrow; plasma cells; free light chains; monoclonal immunoglobulins;
D O I
10.3324/haematol.11133
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Increases in free light chain (FLC) production are associated with disease progression in multiple myeloma (MM). Using a double immunofluorescence staining method to produce a differential count of plasma cells in bone marrow, single populations were demonstrated, containing intact monoclonal immunoglobulins (M-Igs) in 74% and FLCs only in 8% of cases. However, 18% contained a mixture of both cell populations. Progression from cells making intact M-Ig to cells restricted to FLC only production occurred in individual cases during the course of their disease. The presence of FLC only cells was associated with shortened survival.
引用
收藏
页码:1135 / 1138
页数:4
相关论文
共 11 条
[2]
Serum test for assessment of patients with Bence Jones myeloma [J].
Bradwell, AR ;
Carr-Smith, HD ;
Mead, GP ;
Harvey, TC ;
Drayson, MT .
LANCET, 2003, 361 (9356) :489-491
[3]
Extramedullary relapse of multiple myeloma associated with a shift in secretion from intact immunoglobulin to light chains [J].
Dawson, Mark A. ;
Patil, Sushrut ;
Spencer, Andrew .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (01) :143-144
[4]
International uniform response criteria for multiple myeloma [J].
Durie, B. G. M. ;
Harousseau, J-L ;
Miguel, J. S. ;
Blade, J. ;
Barlogie, B. ;
Anderson, K. ;
Gertz, M. ;
Dimopoulos, M. ;
Westin, J. ;
Sonneveld, P. ;
Ludwig, H. ;
Gahrton, G. ;
Beksac, M. ;
Crowley, J. ;
Belch, A. ;
Boccadaro, M. ;
Turesson, I. ;
Joshua, D. ;
Vesole, D. ;
Kyle, R. ;
Alexanian, R. ;
Tricot, G. ;
Attal, M. ;
Merlini, G. ;
Powles, R. ;
Richardson, P. ;
Shimizu, K. ;
Tosi, P. ;
Morgan, G. ;
Rajkumar, S. V. .
LEUKEMIA, 2006, 20 (09) :1467-1473
[5]
GREIPP PR, 1993, BLOOD, V81, P3382
[6]
[7]
Kunnemund A, 2005, ONKOLOGIE S3, V28, P165
[8]
Review of 1027 patients with newly diagnosed multiple myeloma [J].
Kyle, RA ;
Gertz, MA ;
Witzig, TE ;
Lust, JA ;
Lacy, MQ ;
Dispenzieri, A ;
Fonseca, R ;
Rajkumar, SV ;
Offord, JR ;
Larson, DR ;
Plevak, ME ;
Therneau, TM ;
Greipp, PR .
MAYO CLINIC PROCEEDINGS, 2003, 78 (01) :21-33
[9]
Serum free light chains for monitoring multiple myeloma [J].
Mead, GP ;
Carr-Smith, HD ;
Drayson, MT ;
Morgan, GJ ;
Child, JA ;
Bradwell, AR .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (03) :348-354
[10]
Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance [J].
Rajkumar, SV ;
Kyle, RA ;
Therneau, TM ;
Clark, RJ ;
Bradwell, AR ;
Melton, LJ ;
Larson, DR ;
Plevak, MF ;
Katzmann, JA .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (03) :308-310